3S-YP: Social Media, Smartphone Use and Self-harm in Young People

Sponsor
King's College London (Other)
Overall Status
Recruiting
CT.gov ID
NCT04601220
Collaborator
(none)
600
1
28.9
20.7

Study Details

Study Description

Brief Summary

Self-harm is when somebody hurts their body as a way of coping with difficult feelings. Self-harm is becoming increasingly common in young people, particularly in adolescent females. The rise in self-harm has been linked to increasing use of social media and internet technology among young people. However, the evidence is limited to associations with poorer mental health outcomes rather than identifying particular aspects of using these technologies that can negatively impact on mental health.

This study aims to investigate how use of social media and smartphones may increase the risk of self-harm in young people by exploring changes in usage in the time leading up to a self-harm episode. The information from this study will be useful for understanding whether there are certain behaviours that are likely to occur before a young person has an episode of self-harm. This could be used to inform new strategies to identify and ensure support is available to vulnerable young people. This could be by linking young people with crisis support or empowering young people to make changes, manage their own risks and build resilience.

The study will involve young people aged between 13-25 years old who have accessed mental health services in London. Young people will be invited to provide a range of information about their mental health and use of social media and smartphones that will be routinely obtained over the course of a year.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Social Media, Smartphone Use and Self-harm in Young People
    Actual Study Start Date :
    Jun 3, 2021
    Anticipated Primary Completion Date :
    Nov 1, 2022
    Anticipated Study Completion Date :
    Nov 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Frequency of self-harm episodes [12 months]

      Hospital reported or self-reported episodes of self-harm

    Secondary Outcome Measures

    1. Frequency of sleep disturbance symptoms [12 months]

      Symptoms of sleep disturbance measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form V1.0 4a / Pediatric Sleep Disturbance Short Form V1.0 4a. Scores range between 4-20, with higher scores indicative of possible sleep disturbance.

    2. Frequency of depression symptoms [12 months]

      Symptoms of depression measured using the Patient Health Questionnaire. Scores range between 0-27, with higher scores indicative of possible depression.

    3. Frequency of anxiety symptoms [12 months]

      Symptoms of anxiety measured using the Generalized Anxiety Disorder Scale. Scores range between 0-21, with higher scores indicative of possible generalised anxiety disorder.

    4. Frequency of loneliness symptoms [12 months]

      Symptoms of loneliness measured using the Three-Item Loneliness Scale. Scores range between 3-9, with higher scores indicative of possible loneliness.

    5. Frequency of experiences of bullying [12 months]

      Experiences of being bullied measured using an Eight-Item Bullying Checklist derived from the Revised Olweus Bully/Victim Questionnaire. Scores range between 8-40, with higher scores indicative of more experiences of being bullied.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 25 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Young people aged between 13 and 25 years old at the time of recruitment.

    • Young people who have been referred to secondary mental health services in London within the past 12 months.

    • Young people who have been identified from the mental health research participation register or direct referral from a clinician.

    • Young people who have the mental capacity to consent.

    • For young people who are less than 16 years old, the adult with parental responsibility must also have the capacity to consent.

    Exclusion Criteria:
    • Young people aged less than 13 or more than 25 years old at the time of recruitment.

    • Young people who have not had been referred to secondary mental health services in London within the past 12 months.

    • Young people who have not been identified from a mental health research participation register or direct referral from a clinician.

    • Young people who lack the mental capacity to consent.

    • For young people who are less than 16 years old, the adult with parental responsibility does not have the capacity to consent.

    • Young people who are unable to complete the self-report measures via the study software application or an online survey platform.

    • Young people admitted to an inpatient psychiatric ward at the time of recruitment.

    • Young people who require a consultant to be notified of the research prior to contact, as this may indicate higher risk.

    • Young people who are pregnant at the time of approach.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 South London and Maudsley NHS Foundation Trust London United Kingdom

    Sponsors and Collaborators

    • King's College London

    Investigators

    • Principal Investigator: Rina Dutta, King's College London

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    King's College London
    ClinicalTrials.gov Identifier:
    NCT04601220
    Other Study ID Numbers:
    • 269104
    First Posted:
    Oct 23, 2020
    Last Update Posted:
    Oct 21, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by King's College London
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 21, 2021